 SOLANA BEACH, Calif., June 08, 2021 GLOBE NEWSWIRE -- Evoke Pharma, Inc. NASDAQ: EVOK, a specialty pharmaceutical company focused on treatments for gastrointestinal GI diseases, today announced that its US patent No. 11,020,361 for Gimoti metoclopramide nasal spray is now listed in the U.S. Food and Drug Administration FDA publication, Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. The patent covers methods of use for nasal delivery of metoclopramide for the treatment of gastroparesis. 